Scientific Sessions 2025  /  Moving the Needle: Valve Disease in the Young and Moderate Risk  /  TEER for Moderate MR: Treat it!
Logo

American Heart Association

  35
  0

Final ID:

TEER for Moderate MR: Treat it!

  • Asgar, Anita  ( INSTITUT DE CARDIOLOGIE DE MONTREAL , Montreal , Quebec , Canada )
  • Shuvy, Mony  ( Jesselson Integrated Heart Center , Jerusalem , Israel )
    • Author Disclosures:
    Anita Asgar: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Consultant:W. L.Gore:Active (exists now) ; Consultant:Edwards:Active (exists now) ; Consultant:Anteris:Active (exists now) ; Consultant:Medtronic:Active (exists now) | Mony Shuvy: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Moving the Needle: Valve Disease in the Young and Moderate Risk

Monday, 11/10/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
How Young is Too Young for TAVR?: TAVR Should be Kept to Older Patients

Bonow Robert, Ogara Patrick

How Low (Risk) Can You Go? TAVR regardless of risk

Russo Mark, Tang Gilbert

More abstracts from these authors:
Valvular Interventions in the Management of Acutely Decompensated Heart Failure and Cardiogenic Shock

Shuvy Mony, Akodad Mariama, Harari Rafael

Current Indications for TEER and Transcatheter Therapy in Mitral and Tricuspid Disease

Asgar Anita, Rodes-cabau Josep

You have to be authorized to contact abstract author. Please, Login
Not Available